Allogene upgraded by Citizens JMP with a new price target
$ALLO
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Citizens JMP upgraded Allogene from Mkt Perform to Mkt Outperform and set a new price target of $5.00
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
5/14/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | |
3/14/2025 | $5.00 | Mkt Perform → Mkt Outperform | Citizens JMP |
8/8/2024 | $13.00 → $11.00 | Outperform | Oppenheimer |
5/31/2024 | $11.00 | Overweight | Piper Sandler |
1/5/2024 | Mkt Outperform → Mkt Perform | JMP Securities | |
1/5/2024 | Buy → Neutral | Guggenheim | |
12/8/2023 | $7.00 | Buy | Citigroup |
12/8/2023 | Buy | Citigroup |